Growth hormone replacement therapy (GHRT) in children and adolescents: skeletal impact.
AffiliationDepartment of Endocrinology, Christie Hospital, Withington, Manchester, United Kingdom.
MetadataShow full item record
AbstractIn addition to its well-established effects on linear growth in childhood and adolescence, growth hormone has both direct and indirect actions on bone remodelling and homeostasis. In this review the limitations of methods of assessment of bone mineral density are highlighted. The influence of growth hormone deficiency of childhood-onset, on bone mineral accretion and, the specific skeletal implications of GHD in long-term survivors of childhood cancers, are discussed. Specific influential factors, which affect peak bone mass achievement and therefore skeletal health in later life, are evaluated.
CitationGrowth hormone replacement therapy (GHRT) in children and adolescents: skeletal impact. 2003, 41 (3):235-42 Med. Pediatr. Oncol.
JournalMedical and Pediatric Oncology
- Skeletal requirements for optimal growth hormone replacement in the transitional years.
- Authors: Mukherjee A, Attanasio AF, Shalet SM
- Issue date: 2003 Aug
- Effects of 18-month of growth hormone (GH) replacement therapy in patients with Sheehan's syndrome.
- Authors: Tanriverdi F, Unluhizarci K, Kula M, Guven M, Bayram F, Kelestimur F
- Issue date: 2005 Jun
- Comparative results of a 4-year study on cardiovascular parameters, lipid metabolism, body composition and bone mass between untreated and treated adult growth hormone deficient patients.
- Authors: Fideleff HL, Boquete HR, Stalldecker G, Giaccio AV, Sobrado PG
- Issue date: 2008 Aug
- Growth and hormone deficiency and peak bone mass.
- Authors: Bouillon R, Prodonova A
- Issue date: 2000
- Growth hormone therapy and fracture risk in the growth hormone-deficient adult.
- Authors: Johannsson G, Ohlsson C
- Issue date: 1998 Jul